课件：LTRA在哮喘治疗中的重要性.ppt

MS* Ref 3, p 9, C2, ?2, L1-2; p 10, C1, ?1, L1-3; p 12, C2, ?1, L4-6, C2, ?2, L6-8; p 13, Table 6; p 14, Fig. 3 Reference: Malmstrom K, Rodriguez-Gomez G, Guerra J, et al; for 孟鲁司特/倍氯米松 Study Group. Oral 孟鲁司特, inhaled 倍氯米松, and placebo for chronic asthma. Ann Intern Med. 1999;130:487–495. Reference: Tantisira KG, Lake S, Silverman ES, et al. Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with 吸入性皮质类固醇s. Hum Mol Genet. 2004;13:1353–1359. Reference: Martin RJ, Szefler SJ, King TS, et al; for National Heart, Lung, and Blood Institute’s Asthma Clinical Research Center. The Predicting Response to 吸入性皮质类固醇 Efficacy （PRICE）trial. J Allergy Clin Immunol. 2007;119:73–80. MS* Reference: Martin RJ, Szefler SJ, King TS, et al; for National Heart, Lung, and Blood Institute’s Asthma Clinical Research Center. The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial. J Allergy Clin Immunol. 2007;119:73–80. 1/Martin, p 75, C2, ?1, L6-7; p 76, C1, ?2, L2-5; Fig 2 + legend + calc: 1+1+2+4+9+16+11=44 13+2+4+2+3+1+1+2=28 1/Martin, p 76, C1, ?2, L5-9 Graph: 1/Martin, p 76, Fig 2 p 75, C2, ?1, L6-7 (N) Bullets: 1/Martin, p 76, C1, ?2, L2-4 Table: 1/Martin, p 76, Table II, L1,2 Footnote “a”: 1/Martin, p 76, Fig 2 legend Footnote “b”: 1/Martin, p 76, Table II footnote “*” SGA-2009-W-1278807-SS References: National Asthma Education and Prevention Program, National Heart, Lung, and Blood Institute, National Institutes of Health. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Full?Report 2007. Bethesda, MD: US Department of Health and Human Services. Published August 2007. NIH?publication 07-4051. /guidelines/asthma/asthgdln.pdf. Accessed 9 August 2010. Global Initiative for Asthma （GINA）. Global Strategy for Asthma Management and Prevention. Updated 2009. /Guidelineitem.asp??l1=2l2=1intId=1561. Accessed 9 August 2010. Bacharier LB, Boner A, Carlsen K-H, et